Romvimza (Vimseltinib)

Romvimza (vimseltinib) is a kinase inhibitor used for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection is not an option and will potentially cause worsening functional limitation or severe morbidity.

Recommended Dosage: The recommended dosage is 30 mg orally taken twice weekly, with a minimum of 72 hours between doses, as directed on the blister package. Instruct patients to follow the schedule on the blister package and to take dosage on the same days each week. Capsules may be taken with or without food. Swallow the capsules whole. It is not advisable to open, break, or chew the oral capsules.

If a dose is missed by 48 hours or less, take the missed dose as soon as possible and take the next dose on its regularly scheduled day. If a dose is missed by more than 48 hours, skip the missed dose and take the next dose on its regularly scheduled day. If vomiting occurs within 30 minutes of taking a prescribed dose, repeat that dose. Otherwise, take the next prescribed dose on its regularly scheduled day.

• Therapy with Vimseltinib may cause liver toxicity, leading to elevated liver enzymes. Regular liver function tests (LFTs) are important. Patients with pre-existing liver conditions should use this drug cautiously. Monitor for jaundice, dark urine, or unusual fatigue, and seek medical attention if symptoms occur.
• Treatment with this oral therapeutic drug may harm an unborn baby if taken during pregnancy. Women of childbearing potential should use effective contraception during treatment and for a specified period after discontinuation. If pregnancy occurs, discuss risks and alternatives with a healthcare provider (HCP) immediately.
• This oral medicine can cause elevated creatinine levels, which may not indicate kidney damage. Routine kidney function tests are advised to distinguish benign creatinine rise from actual renal impairment. Patients should stay hydrated and report any swelling, fatigue, or changes in urination.
• Vimseltinib 14 mg, 20 mg, or 30 mg is not recommended during pregnancy due to potential risks to the fetus. A pregnancy test is required before starting treatment with this drug. If a patient becomes pregnant, stop treatment immediately and discuss alternative options with a doctor.
• Breastfeeding is not advised during treatment and for a specified time after discontinuation. The drug may pass into breast milk and harm the infant. Patients should consider alternative feeding options to ensure infant safety.

What documents are required to import ROMVIMZA to India?

ROMVIMZA (vimseltinib) capsules can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How is the order to be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit, if applicable

Is ROMVIMZA available in India?

ROMVIMZA (vimseltinib capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On the availability of Romvimza in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait,
• Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

ROMVIMZA can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of ROMVIMZA (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Romvimza 14 mg/20 mg/30 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source ROMVIMZA (Cancer Treatment Medicines) from across the globe and can supply them. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Romvimza®?

Vimseltinib is a Generic Name for the trade name drug Romvimza®.

What is the Manufacturer's Name of Romvimza®?

Romvimza® is manufactured by Deciphera Pharmaceuticals, Inc..

Is Romvimza approved by the FDA?

Yes, Romvimza® is approved by the FDA. Date of first approval: February 14, 2025.

What is the dosage and form of Romvimza® supplied?

Romvimza is supplied in Capsules: 14 mg, 20 mg, 30 mg for oral administration.

What are the most common side effects of Romvimza® Capsules?

The most common side effects of Romvimza® oral Capsules are fatigue, periorbital edema, rash, face edema, peripheral edema, and pruritus.

How much does Romvimza® Capsule cost in India?

The prices of Romvimza oral capsules may fluctuate over time due to market dynamics and regulatory changes. To get the most recent and transparent Romvimza capsules cost in India, please call/WhatsApp +91-9310090915 or email info@indianpharmanetwork.in.

Can Romvimza® Capsules be available in SAARC countries?

Apart from Gulf countries, Romvimza® is available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). The Indian Pharma Network (IPN) can help facilitate the legal supply of Romvimza® oral capsules in these countries. We use reliable channels to ensure legal access to this therapeutic drug.

Is it safe to buy Romvimza® Capsules online in India?

Yes, one can buy Romvimza Capsules online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Romvimza® oral capsules through legal channels.

What are the storage conditions of Romvimza® Capsules?

Store the capsules at controlled room temperature 20 to 25°C (68 to 77°F); excursions permitted to 15 to 30°C (59 to 86°F).